JRVMF yields 23391.81% · JNJ yields 2.13%● Live data
📍 JRVMF pulled ahead of the other in Year 1
Combined, JRVMF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of JRVMF + JNJ for your $10,000?
Jervois Global Limited explores for and evaluates mineral properties in the United States, Brazil, Finland, Australia, and internationally. The company explores for cobalt, nickel, copper, and gold deposits. It holds 100% interest in the Idaho Cobalt Operations project located in the state of Idaho; the São Miguel Paulista nickel cobalt refinery in São Paulo, Brazil; and the Nico Young nickel-cobalt deposits in New South Wales. The company is also involved in the mine construction, refinery studies, and cobalt chemical production activities. In addition, it provides a portfolio of cobalt-based products for chemical, catalyst, inorganic pigment, powder metallurgy and battery industries through its facilities in Kokkola. The company was formerly known as Jervois Mining Limited and changed its name to Jervois Global Limited in August 6, 2021. Jervois Global Limited was incorporated in 1962 and is based in Cremorne, Australia.
Full JRVMF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.